| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/07/2008 | US20080188423 Pi-3 kinase inhibitor prodrugs |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | DE102008000237A1 Mixtures, useful e.g. as an inhibitor or retarder for the stabilization of polymerizable compound, preferably swellable hydrogel-forming polymers, comprises a phenol imidazole derivative and a polymerizable compound |
| 08/07/2008 | CA2702647A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | CA2677204A1 Process for the preparation of (r)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-yl )-1,3-dihydroimidazole-2-thione |
| 08/07/2008 | CA2677203A1 Process for the preparation of (r) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1, 3-dihydroimidazole-2-thione |
| 08/07/2008 | CA2676984A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/06/2008 | EP1953152A1 Process for preparing quinazoline RHO-kinase inhibitors and intermediates thereof |
| 08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
| 08/06/2008 | EP1953145A1 Heterocyclic compound having inhibitory activity on 11- -hydroxysteroid dehydrogenase type i |
| 08/06/2008 | EP1951842A1 Use of rylene derivatives as photosensitizers in solar cells |
| 08/06/2008 | EP1951707A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 08/06/2008 | EP1951706A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 08/06/2008 | EP1951701A2 Ep2 receptor agonists |
| 08/06/2008 | EP1951689A1 P2x7 receptor antagonists and methods of use |
| 08/06/2008 | EP1951683A1 Pyrimidine derivatives for the treatment of cancer |
| 08/06/2008 | EP1951678A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 08/06/2008 | EP1951676A2 Lxr modulators |
| 08/06/2008 | EP1951674A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 08/06/2008 | EP1951673A2 Heterocyclic cetp inhibitors |
| 08/06/2008 | EP1951667A2 Thrombopoietin activity modulating compounds and methods |
| 08/06/2008 | EP1951665A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof |
| 08/06/2008 | EP1773768A4 Pyrrole derivatives as pharmaceutical agents |
| 08/06/2008 | EP1638943B1 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 08/06/2008 | EP1532113B1 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 08/06/2008 | EP1423383B1 Pyridine substituted furan derivatives as raf kinase inhibitors |
| 08/06/2008 | EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 08/06/2008 | CN101238119A Process for the preparation of olmesartan medoxomil |
| 08/06/2008 | CN101238118A Salts and polymorphs of a VEGF-R inhibitor |
| 08/06/2008 | CN100408591C Crystal of pyrimidine nucleoside derivative |
| 08/06/2008 | CN100408574C Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408570C EP4 receptor antagonists |
| 08/06/2008 | CN100408565C Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives |
| 08/06/2008 | CN100408564C Pyrazole derivatives for treating HIV |
| 08/06/2008 | CN100408556C Modulation of anxiety through blockade of anandamide hydrolysis |
| 08/05/2008 | US7408067 Neuregulins such as 4-(4-Hydroxyphenylthio)-piperidine trifluoroacetate for treatment of dysfunctions of central and autonomic nervous systems |
| 08/05/2008 | US7407981 e.g., N-butyl-6-chloro-5-phenyl-1H-indazol-3-amine; kinase inhibitor; obesity and stroke; diseases involving phosphorylation of the tau protein such as Alzheimer's disease, Parkinson's disease, frontoparietal dementia |
| 08/05/2008 | US7407980 Therapeutic agents for treating central nervous system disorders, incotinence, sexual disorders, NASAL CONGESTION; ALPHA 1 ADRENERGIC AGONISTS; N-[4-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-phenyl]-methanesulfonamide; chemical synthesis by cyclization |
| 08/05/2008 | US7407975 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407968 Compounds |
| 08/05/2008 | US7407963 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 08/05/2008 | US7407961 Adenosine antagonists; depression, dementia (e.g. Alzheimer's disease), Parkinson's disease, anxiety, pain, cerebrovascular disorders, heart failure, hypertension, edema, obesity, bronchial asthma |
| 08/05/2008 | US7407958 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 08/05/2008 | US7407956 Benzamide inhibitors of the P2X7 receptor |
| 08/05/2008 | US7407950 N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands |
| 08/05/2008 | US7407644 Covalently binding an antioxidant such as ascorbic acid, p-aminobenzoic acid, cysteine, monothioglycerol, or gentisic acid with ligand: Oxa-PnAO, N,N-dimethyl Gly-Ser-Cys-Gly, N,N-dimethyl-Gly-t-butylGly-Cys-Gly, or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; optional targeting molecule |
| 08/05/2008 | CA2505968C Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 08/05/2008 | CA2426632C Atorvastatin hemi-calcium form vii |
| 08/05/2008 | CA2417081C New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 08/05/2008 | CA2337098C Anthranilic acid derivatives |
| 08/05/2008 | CA2268450C Neurotrophin antagonist compositions |
| 08/05/2008 | CA2180074C Process for the preparation of 3-hydroxyoxetanes |
| 07/31/2008 | WO2008091580A2 Fungicidal amides |
| 07/31/2008 | WO2008091021A1 Heterocyclidene-n-(aryl)acetamide derivative |
| 07/31/2008 | WO2008090046A1 Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone |
| 07/31/2008 | WO2008089933A2 Benzoquinazole derivatives |
| 07/31/2008 | WO2008068423A3 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 07/31/2008 | WO2008062424A3 Substituted 4,5-dihydro-1h-pyrazole derivatives as cannabinoid modulators |
| 07/31/2008 | WO2008061236A3 Sulfoximines as kinase inhibitors |
| 07/31/2008 | WO2008011557A3 Heteroaryl inhibitors of rho kinase |
| 07/31/2008 | WO2008008493A8 Alkyne-substituted pyridone compounds and methods of use |
| 07/31/2008 | WO2007063556A3 An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs |
| 07/31/2008 | US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182873 Process for the manufacture of hmg-coa reductase inhibitors |
| 07/31/2008 | US20080182860 Pyrimidine Compounds as Purine Receptor Antagonist |
| 07/31/2008 | US20080182854 4-Amino-5-Cyanopyrimidine Derivatives |
| 07/31/2008 | US20080182843 Mitotic Kinesin Inhibitors |
| 07/31/2008 | US20080182840 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 07/31/2008 | US20080182839 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives |
| 07/31/2008 | CA2676020A1 Heterocyclidene-n-(aryl) acetamide derivative |
| 07/31/2008 | CA2674921A1 Benzoquinazoline derivatives |
| 07/30/2008 | EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/30/2008 | EP1949896A2 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/30/2008 | EP1948669A1 New methods for the preparation of taxanes using chiral auxiliaries |
| 07/30/2008 | EP1948654A1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 07/30/2008 | EP1948646A2 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 07/30/2008 | EP1948645A1 Tricyclo substituted amides |
| 07/30/2008 | EP1948644A1 Tricyclo substituted amides |
| 07/30/2008 | EP1948643A2 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 07/30/2008 | EP1948605A2 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 07/30/2008 | EP1948603A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 07/30/2008 | EP1948600A2 Liver targeted conjugates |
| 07/30/2008 | EP1948168A2 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 07/30/2008 | EP1747204B1 Tri-substituted ureas as cytokine inhibitors |
| 07/30/2008 | EP1737462B1 Pyrimidines with tie2 (tek) activity |
| 07/30/2008 | EP1685113B1 Substituted pyrazoles as ppar agonists |
| 07/30/2008 | EP1660447B1 Cyclic amine bace-1 inhibitors having a heterocyclic substituent |
| 07/30/2008 | EP1606267B1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 07/30/2008 | EP1592684B1 Malonamide derivatives as gamma-secretase inhibitors |
| 07/30/2008 | EP1377564B1 Transition-metal-catalyzed process for the preparation of sterically hindered n-substituted alkoxyamines |
| 07/30/2008 | EP1054881B1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/30/2008 | CN101233128A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 07/30/2008 | CN101233127A Heterocyclic compound and organic electroluminescent device using same |
| 07/30/2008 | CN101233114A New imidazole carboxamides, useful to treat e.g. pathologies associated with the insulin resistance syndrome, are fructose-1,6-biphosphatase inhibitors |
| 07/30/2008 | CN101233113A Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation |
| 07/30/2008 | CN101233112A Benzoquinazoline derivatives and their use in treating bone disorders |